Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for travel industry professionals · Tuesday, December 11, 2018 · 470,842,451 Articles · 3+ Million Readers

Global Penicillin and Streptomycin Market Research and Forecast 2017-2022

Orion Market Research Pvt. Ltd.

Industry Market Research Report and Consulting

Penicillin and Streptomycin Market, Size, Share, Intelligence, Company Profiles, Market Trends, Strategy, Analysis, Forecast 2017-2022

Increasing incidences of infectious diseases and rising investments in R&D programs will drive the global penicillin and streptomycin market”
— OMR Analyst

INDORE, INDIA, March 12, 2018 /EINPresswire.com/ -- Orion Market Research (OMR), recently published a market research report on global penicillin and streptomycin market. According to OMR analysis, the global penicillin and streptomycin market is expected to grow at a CAGR of 0.5% during 2017-2022. The global Penicillin and Streptomycin market is segmented on the basis of type of products, mode of administration, manufacturing process and end users. The report provides detailed & insightful chapters that include market overview, analyst insights with strategic recommendations, market determinants, market estimations, patent analysis, key company analysis, market insights, company profiling, market segmentation, geographical analysis and predictive analysis of the market.

The full report of global penicillin and streptomycin market is available at https://www.omrglobal.com/industry-reports/penicillin-and-streptomycin-market/

“The global penicillin and streptomycin market is driven by factors such as growing number of infectious diseases and significant R&D investments in healthcare domain. Growth of global penicillin and streptomycin market can also be attributed to increasing demand for generic drugs during the forecast period. Usage of Penicillin-Streptomycin in cell culture is also creating considerable scope for the market.”

Global penicillin and streptomycin market has shown modest growth due to the rising number of contagious diseases across the globe. In North America, the usage of penicillin and streptomycin in cell culture and strong R&D programs in the field are driving the market during the forecast period. Europe follows North America in terms of market share. Government regulations and patent expirations are the major growth inhibitor for the penicillin and streptomycin market in this region. APAC is expected to grow at a healthy pace during the forecast period owing to growing awareness about vaccination and improving healthcare infrastructure. Integration of penicillin and streptomycin systems with advanced technologies and adoption of cloud-based services act as huge opportunities for the market during the forecast period.

The geographical segmentation of penicillin and streptomycin market includes North America, Europe, Asia Pacific, and ROW. North America is expected to dominate the market during the forecast period majorly due to extensive R&D capabilities and usage of penicillin and streptomycin in cell cultures. Increasing geriatric population is also driving market growth in this region. However, Asia Pacific is likely to achieve the fastest growth during the forecast period owing to rising pool of patients in vastly populated regions such as India and China and frequent outbreaks of infectious diseases within the region. The penicillin and streptomycin market have huge opportunities in emerging APAC markets, however strict regulatory scenario and anti-microbial resistance could be a tough challenge for market growth in this region.

Companies Profiled in the Report
7.1. Abbot Laboratories
7.2. Amgen
7.3. Astellas Pharma Inc.
7.4. AstraZeneca
7.5. Bayer Healthcare AG
7.6. Biogen Idec
7.7. Bristol Myers Squibb Co.
7.8. Celgine Corp.
7.9. Eli Lilly and Co.
7.10. Gilead Sciences Inc.
7.11. GlaxoSmithKline Plc
7.12. Johnson & Johnson
7.13. Merck & Co., Inc.
7.14. Middlebrook Pharmaceuticals
7.15. Novartis AG
7.16. Pfizer
7.17. Roche Pharmaceuticals
7.18. Sanofi Aventis SA
7.19. Takeda Pharmaceutical Company
7.20. Toyama Chemical Co. Ltd

For related reports please visit: https://www.omrglobal.com/reports-category/pharmaceuticals/

About Orion Market Research
Orion Market Research (OMR) is an Indian research company known for its crisp and concise reports. The company is equipped with an experienced team and young brigade of analysts. The company provides quality syndicated research reports, customized research reports, Company Profiling, consulting and other research-based services. OMR provides global and regional market reports of various domains such as healthcare, energy, IT, chemicals, and automobiles. OMR provide a 360-degree analysis of the market with parametric analysis, key market insights, key findings, statistical forecasts, competitive landscape, extensive segmentation, key trends, strategic recommendations and detailed company profiles.

Anurag Tiwari
Orion Market Research Pvt. Ltd.
+919179828694
email us here

Powered by EIN Presswire


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release